- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
SK Biopharmaceuticals
Market Cap: ₩6.0t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩76,800.00
7D
-1.8%
1Y
-24.5%
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩29,300.00
7D
-4.1%
1Y
-14.0%
JW Shinyak
Market Cap: ₩117.3b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,100.00
7D
12.3%
1Y
30.6%
DongKoo Bio & Pharma
Market Cap: ₩99.5b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩3,680.00
7D
-1.6%
1Y
-29.5%